These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
140 related items for PubMed ID: 2788539
1. Heterogeneity of B cell responsiveness to interleukin 4, interleukin 6 and low molecular weight B cell growth factor in discrete stages of B cell activation in patients with systemic lupus erythematosus. Kitani A, Hara M, Hirose T, Norioka K, Harigai M, Hirose W, Suzuki K, Kawakami M, Kawagoe M, Nakamura H. Clin Exp Immunol; 1989 Jul; 77(1):31-6. PubMed ID: 2788539 [Abstract] [Full Text] [Related]
2. Characterization of B cell growth in systemic lupus erythematosus. Effects of recombinant 12-kDa B cell growth factor, interleukin 4 and transforming growth factor-beta. Flescher E, Fossum D, Ballester A, Maizel A, Sharma S, Talal N. Eur J Immunol; 1990 Nov; 20(11):2425-30. PubMed ID: 2253682 [Abstract] [Full Text] [Related]
3. B cell hyperactivity in systemic lupus erythematosus: selectively enhanced responsiveness to a high molecular weight B cell growth factor. Delfraissy JF, Wallon C, Vazquez A, Dugas B, Dormont J, Galanaud P. Eur J Immunol; 1986 Oct; 16(10):1251-6. PubMed ID: 3095124 [Abstract] [Full Text] [Related]
4. [Spontaneous production of interleukin-1 and B cell stimulating factors by B cells from patients with systemic lupus erythematosus]. Hirose T. Ryumachi; 1989 Aug; 29(4):277-83. PubMed ID: 2617369 [Abstract] [Full Text] [Related]
10. Low molecular weight B cell growth factor-responsive cloned human B cell lines. I. Phenotypic differences and lack of requirement for CD23 (Fc epsilon RII). Warrington RJ, Rutherford WJ, Wong SK, Cook JM, Rector ES. J Immunol; 1989 Oct 15; 143(8):2546-52. PubMed ID: 2529311 [Abstract] [Full Text] [Related]
11. Sequential effect of a high molecular weight B cell growth factor and of interleukin 2 on activated human B cells. Vazquez A, Auffredou MT, Gerard JP, Delfraissy JF, Galanaud P. J Immunol; 1987 Oct 01; 139(7):2344-8. PubMed ID: 3116080 [Abstract] [Full Text] [Related]
12. Inhibitory effect of anti-class II antibody on the spontaneous activation of B cells in patients with systemic lupus erythematosus. Analysis with IL-1 production and IL-1 receptor expression. Tanaka Y, Saito K, Suzuki H, Eto S, Yamashita U. J Immunol; 1989 Sep 01; 143(5):1584-90. PubMed ID: 2527267 [Abstract] [Full Text] [Related]
13. Production of B cell-stimulating factors by B cells in patients with systemic lupus erythematosus. Tanaka Y, Saito K, Shirakawa F, Ota T, Suzuki H, Eto S, Yamashita U. J Immunol; 1988 Nov 01; 141(9):3043-9. PubMed ID: 3262675 [Abstract] [Full Text] [Related]
16. Heterogeneity of responsiveness of chronic lymphocytic leukemic B cells to B cell growth factor or interleukin 2. Hivroz C, Grillot-Courvalin C, Brouet JC, Seligmann M. Eur J Immunol; 1986 Aug 01; 16(8):1001-4. PubMed ID: 3488907 [Abstract] [Full Text] [Related]
17. The effects of interleukin 1 on human B cell activation and proliferation. Falkoff RJ, Muraguchi A, Hong JX, Butler JL, Dinarello CA, Fauci AS. J Immunol; 1983 Aug 01; 131(2):801-5. PubMed ID: 6602846 [Abstract] [Full Text] [Related]
18. Pre-exposure of human B cells to recombinant IL-1 enhances subsequent proliferation. Freedman AS, Freeman G, Whitman J, Segil J, Daley J, Nadler LM. J Immunol; 1988 Nov 15; 141(10):3398-404. PubMed ID: 3141499 [Abstract] [Full Text] [Related]
19. Induction of excessive B cell proliferation and differentiation by an in vitro stimulus in culture in human systemic lupus erythematosus. Suzuki N, Sakane T. J Clin Invest; 1989 Mar 15; 83(3):937-44. PubMed ID: 2646322 [Abstract] [Full Text] [Related]
20. Human recombinant IL-4 induces activated B lymphocytes to produce IgG and IgM. Defrance T, Vanbervliet B, Pène J, Banchereau J. J Immunol; 1988 Sep 15; 141(6):2000-5. PubMed ID: 2971718 [Abstract] [Full Text] [Related] Page: [Next] [New Search]